Evidence supporting a role for CXCL1 in CRC pathology was recently provided by a study demonstrating an association between increased expression of CXCL1 and down-regulation of the matrix protein fibulin-1, which is known to suppress the motility of various cancer cells [32]. Here, FBLN1 is linked to cancer.